Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Mar 7;21(6):1029–1036. doi: 10.1016/j.bbmt.2015.02.018

Table 2.

Multivariate analysis of 6-month survival.

BMT CTN 0302 BMT CTN 0802
Variable HR 95% CI p HR 95% CI p
Age > 40 years 3.9 1.1 – 17.7 0.03 3.3 1.1 – 14.6 0.03
Grade 0.17 0.07
 1 1.0 - 1.0 -
 2 2.0 0.34 – 39.0 0.7 0.2 – 2.7
 3 5.1 0.85 – 100.8 2.0 0.5 – 8.7
 4 2.8 × 108 0 – 132.6 1.8 × 109 0 – 2.2
Day 28 Response 0.01 0.001
 CR 1.0 - 1.0 -
 PR 0.7 0.2 – 2.6 1.7 0.4 – 6.1
 NR 3.7 1.2 – 11.4 5.0 2.0 – 13.7
Day 28 FS ≥ 2000 pg/ml 9.3 1.3 – 59.1 0.002 2.8 1.04 – 6.9 0.04
Onset Ang2 ≥ 8000 pg/ml 3.0 0.6 – 11.7 0.05 0.3 0.03 – 1.2 0.09
Day 28 Ang2 ≥ 8000 pg/ml 0.6 0.05 – 5.1 0.14 5.2 1.7 – 13.9 0.006
Day 28 sEng ≥ 3000 pg/ml 0.9 0.04 – 8.5 0.6 1.1 0.5 – 2.6 0.7
Day 28 PlGF ≥ 20 pg/ml 4.7 1.4 – 21.7 0.005 1.8 0.6 – 6.7 0.3

Abbreviations: Ang2=angiopoetin-2, CI=confidence interval, CR=complete response, FS=follistatin, HR=hazard ratio, NR=no response, PlGF=placental growth factor, PR=partial response.